Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose
If approved it will bring a second source of MMR vaccine to the US market
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
Filing for WHO Emergency Use Authorisation this month
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
Deal for 100 million doses with additional 100 million through 2023
AstraZeneca, Sinopharm and Moderna were part of the study
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
Subscribe To Our Newsletter & Stay Updated
